-+ 0.00%
-+ 0.00%
-+ 0.00%

Travere Therapeutics Q4 Earnings Report: What Investors Need to Know

Benzinga·02/19/2026 21:04:41
Listen to the news

Travere Therapeutics (NASDAQ:TVTX) reported its Q4 earnings results on Thursday, February 19, 2026 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Travere Therapeutics beat estimated earnings by 54.17%, reporting an EPS of $0.37 versus an estimate of $0.24.

Revenue was up $54.90 million from the same period last year.

Historical Earnings Summary

In the previous quarter, the company beat on EPS by $0.76, resulting in a 18.58% increase change in the share price the following day.

Here's a look at Travere Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.17 -0.12 -0.39 -0.38
EPS Actual 0.59 0.13 -0.19 -0.47
Revenue Estimate 105.01M 99.08M 76.86M 72.38M
Revenue Actual 164.86M 114.40M 81.73M 74.79M

To track all earnings releases for Travere Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.